Physician profile
Adrianna Janell Browne
NPI 1699968305
$5,616.79
in general payments reported to CMS, 2019-2025
18 companies · $714 in 2025
The $714 reported for 2025 was less than what a typical Clinical & Laboratory Dermatological Immunology provider received nationally (typical 2025 total: $1,130).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $467 · 2020: $259 · 2021: $883 · 2022: $1,250 · 2023: $1,043 · 2024: $1,001 · 2025: $714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,727 · Education: $30.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,727.18 |
| Education | $30.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $857.58 | 2019-2023 | |
| Pfizer INC. | $601.61 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $489.57 | 2021-2025 | Dupixent |
| Janssen Biotech, INC. | $488.96 | 2019-2024 | Tremfya, Simponi, Remicade |
| Abbvie INC. | $459.26 | 2019-2024 | Skyrizi |
| Revance Therapeutics, INC. | $455.40 | 2024-2025 | Daxxify |
| Lilly USA, LLC | $445.56 | 2019-2024 | Taltz, Olumiant, Ebglyss |
| Incyte Corporation | $372.89 | 2021-2025 | Opzelura |
| Leo Pharma INC. | $339.15 | 2019-2023 | Adbry |
| Galderma Laboratories, L.P. | $278.26 | 2019-2025 | Dysport |
| Novartis Pharmaceuticals Corporation | $260.03 | 2021-2025 | |
| Allergan, INC. | $209.13 | 2020-2022 | |
| Ucb, INC. | $118.97 | 2024-2025 | Bimzelx |
| Biofrontera INC. | $88.20 | 2019-2024 | Xepi, Bf-Rhodoled, Ameluz |
| Arcutis Biotherapeutics, INC. | $44.83 | 2024-2025 | Zoryve |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $42.76 | 2023-2025 | Jublia, Arazlo, Duobrii |
| Merz North America, INC. | $41.78 | 2022 | |
| Organon LLC | $22.85 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrianna Browne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.